Hyperhomocysteinemia – an early marker of retinal damage in patients with type 2 diabetes mellitus
Wiadomości Lekarskie · 2025
DOI: 10.36740/wlek/213600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wiadomości Lekarskie, 2025. Verfasst von Yelyzaveta S Sirchak und 5 weiteren Autor:innen. Beteiligte Einrichtung: UZHHOROD NATIONAL UNIVERSITY, UZHHOROD, UKRAINE. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Retinopathy, Hyperhomocysteinemia, Homocysteine. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
To investigate the features of changes in serum homocysteine (Hcy) levels in patients with T2DM depending on the presence or absence of retinal damage. Materials and Methods: We observed 77 patients with T2DM. Patients were divided into two groups: group 1 included 45 patients with T2DM and diabetic retinopathy (DR), group 2 included 32 patients with T2DM without DR. The level of Hcy concentration and B vitamins (vitamin B1, B6, B9, B12) was determined in blood serum.
Results
Proliferative and preproliferative stages of DR were more frequently detected in the examined patients with T2DM (in 44.4% and 26.7% of patients, respectively). Proliferative retinopathy with complications was diagnosed in 17.8% of patients, while nonproliferative retinopathy with maculopathy was diagnosed only 11.1% of cases. In patients of both groups, a decrease in the levels of B vitamins in the blood serum was detected, which was detected against the background of an increase in the level of homocysteine in the blood serum in these patients.
Conclusions
In patients with type 2 diabetes and DR, a decrease in the level of B vitamins was found against the background of an increased concentration of homocysteine (43.5±0.9 mkmol/l – p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UZHHOROD NATIONAL UNIVERSITY, UZHHOROD, UKRAINE.
Zitieren
APA
Sirchak, Y. S., Stoika, A. V., Dobryanska Opalenyk, E. S., Bedey, N. V., Pushkash, I. I., & Holosh, Y. V. (2025). Hyperhomocysteinemia – an early marker of retinal damage in patients with type 2 diabetes mellitus. Wiadomości Lekarskie. https://doi.org/10.36740/wlek/213600
Vancouver
Sirchak YS, Stoika AV, Dobryanska Opalenyk ES, Bedey NV, Pushkash II, Holosh YV. Hyperhomocysteinemia – an early marker of retinal damage in patients with type 2 diabetes mellitus. Wiadomości Lekarskie. 2025. doi:10.36740/wlek/213600
BibTeX
@article{Sirchak2025,
author = {Sirchak, Yelyzaveta S and Stoika, Aliona V and Dobryanska Opalenyk, Erica S and Bedey, Nelli V and Pushkash, Ivan I and Holosh, Yuliia V},
title = {Hyperhomocysteinemia – an early marker of retinal damage in patients with type 2 diabetes mellitus},
journal = {Wiadomości Lekarskie},
year = {2025},
doi = {10.36740/wlek/213600}
}
EUVIMED